Variable treatment response in a patient with pyridoxal N phosphate oxidase (PNPO) deficiency- understanding the...

Area of Science:

• Biochemistry
• Genetics
• Neurology

Background:

• Infantile onset epileptic encephalopathy and developmental delay can be caused by genetic factors.
• Pyridoxine (vitamin B6) metabolism disorders, such as PNPO deficiency, present with refractory seizures.
• Genetic mutations influence treatment response and vitamin dependency.

Purpose of the Study:

• To describe a novel case of PNPO deficiency with unusual vitamin dependencies.
• To highlight the importance of precise genetic mutation analysis for personalized treatment strategies.
• To report on the management of refractory seizures in a child with PNPO deficiency.

Main Methods:

• Clinical exome sequencing to identify genetic mutations.
• Therapeutic trials with various vitamin supplements (pyridoxine, riboflavin, thiamine, pyridoxal phosphate).
• Monitoring seizure control and treatment response.

Main Results:

• A homozygous mutation (c.352G>A p.Gly118R) in the PNPO gene was identified.
• The patient showed incomplete seizure control with standard pyridoxine therapy.
• Riboflavin dependence and transient worsening of seizures upon pyridoxine withdrawal were observed.
• Combined therapy with pyridoxine, riboflavin, and pyridoxal phosphate achieved good seizure control.

Conclusions:

• PNPO deficiency can present with complex vitamin dependencies beyond pyridoxine.
• Precise genetic mutation analysis is crucial for tailoring vitamin supplementation and managing treatment response.
• This case underscores the need for individualized treatment approaches in genetic epilepsy syndromes.